Extracellular matrix protein synthesis

The **extracellular matrix protein synthesis** process refers to the cellular production, modification, and assembly of proteins that comprise the extracellular matrix (ECM), a dynamic network surrounding cells in all tissues. The ECM consists primarily of collagens, elastins, glycoproteins (fibronectin, laminin), and proteoglycans, each providing structural support and regulating a variety of cellular functions, including growth, differentiation, migration, and survival. ECM protein synthesis is tightly regulated by growth factors, signaling pathways, and enzymatic modification (including cross-linking, glycosylation, and sulfation). Aberrations in ECM synthesis and remodeling are central to diseases such as fibrosis, cancer, and inherited connective tissue disorders. While the process is fundamentally important, therapeutic drug development typically targets individual ECM proteins, modifying enzymes (e.g., matrix metalloproteinases), or the cell-surface receptors that mediate ECM-cell interactions. If you are interested in an individual ECM protein (e.g., collagen type I, fibronectin, laminin), or a synthetic/modifying enzyme (e.g., matrix metalloproteinase, lysyl oxidase), these can be described as specific therapeutic targets. “Extracellular matrix protein synthesis” itself is best considered a biological pathway or process.

Other names

Extracellular matrix biosynthesisECM protein productionECM assembly

Indirect modulation of ECM synthesis or degradation via inhibition/activation of synthetic enzymes (e.g., MMP inhibitors), anti-fibrotic pathways, or signaling molecules